![]() |
|
|
![]() |
![]() |
|
|
|
|
|
| Find Clinical Trials | Contact: (919)966-4432 | ||||||||||||||
| (877)668-0683 | |||||||||||||||
| |||||||||||||||
| Drugs |
- 5-FLUOROURACIL (5-FU)
- 5-FLUOROURACIL (Bolus)
- 5-FLUOROURACIL (Infusion)
- ABRAXANE
- ADRIAMYCIN
- ALIMTA
- ALKERAN
- AMN-107
- AR00142866
- ARA-C
- ARRY142866
- AVASTIN
- AZD6244
- BEVACIZUMAB
- BEXXAR
- BIBW-2992
- BONDRONAT
- BONEFOS
- BORTEZOMIB
- BUSULFAN
- CAMPTOSAR
- CARBOPLATIN
- CC-5013
- CDDP
- CETUXIMAB
- CISPLATIN
- CLODRONATE
- CLOFARABINE
- CLOLAR
- CNTO 328
- CYCLOPHOSPHAMIDE
- CYTARABINE
- CYTOSAR-U
- CYTOXAN
- DAUNOMYCIN
- DAUNORUBICIN
- DECADRON
- DECITABINE
- DENDRITIC CELL VACCINE
- DEXAMETHASONE
- DIFLUCAN
- DOCETAXEL
- DOXORUBICIN
- ELOXATIN
- EM1421
- EPIRUBICIN
- EPIRUBICIN HYDROCHLORIDE
- ERBITUX
- ERLOTINIB
- ETOPOSIDE
- EVEROLIMUS
- FLUCONAZOLE
- FLUOROURACIL
- FOLEX
- FOLINIC ACID
- G-CSF
- GEMCITABINE
- GEMTUZUMAB
- GEMZAR
- GLEEVEC
- GLIADEL WAFER
- GW572016
- HERCEPTIN
- IBANDRONATE
- IBANDRONIC ACID
- IBRITUMOMAB TIUXETAN
- IFEX
- IFOSFAMIDE
- IL-6 ANTIBODY
- IMATINIB
- IRINOTECAN
- KSP INHIBITOR
- L-BLP25
- LAPATINIB
- LEUCOVORIN
- LEUPROLIDE
- LEVAQUIN
- LEVOFLOXACIN
- LUPRON
- MAGNEVIST
- MELPHALAN
- METHOTREXATE
- METHYLPREDNISONE
- MLN8237
- MTX
- MULTIHANCE
- MYLOTARG
- NAVELBINE
- NILOTINIB
- NOLVADEX
- ONCOGEL
- ONCOVIN
- OSI-774
- OXALIPLATIN
- PACLITAXEL
- PANITUMUMAB
- PARAPLATIN
- PEMETREXED
- PLATINOL
- PR1- PEPTIDE
- PREDNISONE
- PS-341
- PSC-341
- PTK787
- RAD-001
- RADIATION THERAPY
- RITUXAN
- RITUXIMAB
- SB-743921
- SOLTAMOX
- SORAFENIB
- STA-4783
- STI-571
- STIMUVAX
- SU011248
- SULINDAC
- SUNITINIB
- SUTENT
- TAMOXIFEN
- TARCEVA
- TASIGNA
- TAXOL
- TAXOTERE
- TERAMEPROCOL
- TOSITUMOMAB
- TRASTUZUMAB
- TYKERB
- VECTIBIX
- VELCADE
- VEPESID
- VINCRISTINE
- VINORELBINE
- VP-16
- WELLCOVORIN
- ZEVALIN
- ZK222584
- ZOLEDRONIC ACID
- ZOMETA
UNC-Chapel Hill • UNC Health Care • UNC School of Medicine • NC Cancer Stories • Privacy Policy • Contact Us
© Copyright 1999-2008
© Copyright 1999-2008








